Tag Archives: BioPlus

August, 2016

  • 10 August

    Finding the Missing Cases

    As many as one in four cases of hepatitis C infection may miss the opportunity to be diagnosed – and this dire statistic is projected to happen even when current federal guidelines for hepatitis C screening are closely followed. As a result, experts now urge new guidelines of universal screening. …

  • 3 August

    HCV Blues

    By some estimates, depression is experienced by up to one in every three people with chronic hepatitis C virus (HCV) infection. This is accounted for, in part, by the risk of depression that occurs in chronic, long-term diseases of all kinds. For hepatitis C specifically, depression remains a common yet …

July, 2016

  • 27 July

    2016 World Hepatitis Day

    The “Elimination” theme of this year’s World Hepatitis Day – coming up on July 28, 2016 – highlights the vision of lessening the world burden of hepatitis. The organizers note that “Every action is an action towards elimination of viral hepatitis.” This theme is echoed by the first-ever establishment by the …

  • 20 July

    Sticking Points

    There are several ‘sticking points’ that get in the way of patients sticking with their prescribed treatment. In fact, medication nonadherence remains a key area of wasted health care resources. A recent article in the Journal of Managed Care and Specialty Pharmacy points out that there are two types of …

  • 13 July

    Extra Care Brings Impressive Results

    Guest Blog by: Bridget Economou, RN, OCN Reflecting back on my time attending the 41st ONS (Oncology Nursing Society) Congress in San Antonio, Texas, I was particularly struck by the data in a poster presentation from Kentucky regarding oral adherence. Their conclusions about how a care team can positively impact …

  • 5 July

    Introducing Epclusa

    The treatment options for hepatitis C infections just gained a member to the club. There are six genotypes (numbered 1-6) of the hepatitis C virus. Previously, hepatitis C medications generally worked best for only one or a few genotypes. Consequently, identifying a patient’s genotype was an important part of the …

June, 2016

  • 22 June

    A Quicker Oncology Pipeline

    Oncology treatment is serious business. Lives are at stake, which is why some oncology researchers advocate for a faster path from drug development to approval. The development of new therapies, for the past several decades, has followed a very clear, step-wise progression. First, there are phase 1 trials to establish …

  • 8 June

    Longevity After Hepatitis C Treatment

    Before direct-acting antiviral medications came on the scene for treating hepatitis C, this disease was often a death sentence for patients who progressed to liver failure or liver cancer. However, over the past few years the newly available treatment options now mean that more than 90% of patients with hepatitis …

  • 6 June

    Managing Hepatitis C Treatment Costs

    Manufacturer coupons for high-cost medications, such as those that treat hepatitis C, make a huge difference for patients. Today’s hepatitis C medications have the potential to cure the majority of infected people; however, they can come with a steep price tag for both patients and payers. In order to bring …

May, 2016

  • 11 May

    Turning the Tide

    The year 2014 reached a gloomy record, when statistics revealed this to be the year with the highest number of hepatitis C-related deaths ever. (This is the most recent year with statistics available.) This followed on the heels of several years with an upward trend in hepatitis C deaths. Baby …